Detection of Neurotic Disorders in Irritable Bowel Syndrome And Study of The Effectiveness of Systematic Desensitization Therapy

Gafurova Sabohat  Shayunusovna

doi:10.17605/cajmns.v6i1.2711

Gafurova Sabohat Shayunusovna Tashkent Medical Academy, Tashkent, Uzbekistan

DOI: https://doi.org/10.17605/cajmns.v6i1.2711

Keywords: irritable bowel syndrome, neurotic disorders, anxiety-phobic disorders, psychotherapy, psychopharmacotherapy, HADS scale

Abstract

Functional gastrointestinal disorders, particularly irritable bowel syndrome (IBS), are significant challenges in modern medicine due to their prevalence and impact on quality of life. IBS affects approximately 10–20% of the global population and is often accompanied by anxiety-phobic disorders, which exacerbate the condition. This study aimed to identify the prevalence of anxiety-phobic disorders in patients with IBS and to evaluate the effectiveness of medical and psychological interventions. A cohort of 70 IBS patients aged 25–55 years was assessed at the Tashkent Medical Academy between 2022 and 2023. Diagnosis was based on clinical, laboratory, and psychological evaluations using the ZR Ibodullaev questionnaire and HADS scale. Treatment protocols included psychotherapy, cognitive therapy, and self-training. Anxiety levels were assessed at baseline and after treatment. Results indicated a significant prevalence of anxiety-phobic disorders among IBS patients, with psychoemotional symptoms contributing to maladaptation and reduced work capacity. After treatment, the main group showed a marked decrease in clinical anxiety (from 9 to 3 patients) and an increase in anxiety-free individuals (from 4 to 24 patients). In contrast, the control group exhibited a moderate improvement. The findings highlight the critical role of psychoemotional factors in IBS pathogenesis and demonstrate that integrating psychotherapy with standard IBS treatment can effectively alleviate anxiety-phobic symptoms. This approach not only improves the psychosocial well-being of patients but also enhances their overall quality of life. Future research should focus on optimizing treatment protocols to address the biopsychosocial nature of IBS.

References

D. S. Danilov, V. D. Morozova, I. G. Korobkova et al., "Irritable bowel syndrome in psychiatric practice," Neurology, Neuropsychiatry, Psychosomatics, no. 2, pp. 46–51, 2013.

S. Sh. Gafurova and S. T. Yusuphadjayeva, "Anxiety-phobic disorders in irritable bowel syndrome and the effectiveness of psychotherapy and psychopharmacotherapy," Innovative Research in Science: International Scientific-Online Conference, p. 8, 2022.

D. A. Drossman and W. L. Hasler, "Rome IV - Functional GI disorders: disorders of gut-brain interaction," Gastroenterology, vol. 150, no. 6, pp. 1257–1261, 2016.

T. Karantanos, T. Markoutsaki, and M. Gazouli et al., "Current insights into the pathophysiology of irritable bowel syndrome," Gut Pathogens, vol. 2, pp. 1–3, 2018.

S. Sh. Gafurova and S. T. Yusuphadjayeva, "Anxiety-phobic disorders in irritable bowel syndrome and the effectiveness of psychotherapy and psychopharmacotherapy in them," Journal International Bulletin of Medical Sciences and Clinical Research, vol. 3, no. 1, pp. 110, 2023.

F. A. Luscombe, "Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review," Quality of Life Research, vol. 9, no. 2, pp. 161–176, 2017.

V. T. Ivashkin and A. A. Sheptulin, Abdominal Pain. Moscow: [Publisher], 2012, p. 112.

L. R. Johnson, Physiology of the Gastrointestinal Tract, 8th ed., vol. 2. New York: Raven, 2018, pp. 929–976.

M. Grover and D. A. Drossman, "Central acting therapies for irritable bowel syndrome," Gastroenterology Clinics of North America, vol. 40, no. 1, pp. 183–206, 2016.

A. D. Ergashov, Z. R. Ibodullaev, and N. M. Maxamatjanova, Journal of Neurology and Neurosurgical Research.

S. Sh. Gafurova and S. T. Yusupxadjayeva, "Differential analysis of neurotic disorders in irritable bowel syndrome and improvement of medical psychological support in them," Science and Innovation, 2023. [Online]. Available: https://doi.org/10.5281/zenodo.7668834

A. A. Samsonov, E. Yu. Baranova, and M. V. Plotnikova et al., "Irritable bowel syndrome - a disease with many unknowns, some therapeutic aspects," Treating Doctor, 2012.

N. M. Maxamatjanova, F. S. Mirxaydarova, and S. M. Mirxaydarova, "The significance of diabetes in the development of depression," Academic Research in Modern Science, vol. 2, no. 7, pp. 19–20.

F. A. Luscombe, "Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review," Quality of Life Research, vol. 9, no. 2, pp. 161–176, 2017.

M. F. Osipenko, E. E. Moiseenko, and S. I. Kholin, "Stressam in the treatment of irritable bowel syndrome," Mental Disorders in General Medicine, no. 13, pp. 19–23, 2012.